A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in ...
A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...
Researchers have developed a generative AI system called CytoDiffusion that can analyze blood cells with a level of precision that rivals, and in some cases exceeds, human experts.
Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its ...
This article was reviewed by Felix Gussone, MD. How to Read Blood Test Results: What “Normal” Really Means for Your Health ...
Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...
News-Medical.Net on MSN
Lymphocyte levels help predict outcomes after CAR T-cell therapy in non-Hodgkin lymphoma
Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...
News Medical on MSN
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukemia
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results